Theratechnologies Inc
NASDAQ:THTX

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
NASDAQ:THTX
Watchlist
Price: 3.39 USD Market Closed
Market Cap: 155.9m USD

Relative Value

The Relative Value of one THTX stock under the Base Case scenario is hidden USD. Compared to the current market price of 3.39 USD, Theratechnologies Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

THTX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
41
vs Industry
87
Median 3Y
1
Median 5Y
1.7
Industry
7.9
Forward
1.8
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-16.1
Industry
23.7
Forward
-45.2
vs History
6
vs Industry
6
Median 3Y
-6.2
Median 5Y
-23.7
Industry
22
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-6.3
Industry
24.3
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-2.8
Industry
3.3
vs History
41
vs Industry
73
Median 3Y
1.1
Median 5Y
2.1
Industry
8.2
Forward
2.1
vs History
41
vs Industry
73
Median 3Y
1.5
Median 5Y
2.7
Industry
10.2
vs History
1
vs Industry
12
Median 3Y
4.5
Median 5Y
-6.4
Industry
6.1
Forward
14.6
vs History
1
vs Industry
10
Median 3Y
5.9
Median 5Y
-4.4
Industry
6.5
Forward
58.1
vs History
6
vs Industry
4
Median 3Y
-6.3
Median 5Y
-31
Industry
7.9
vs History
vs Industry
1
Median 3Y
-11.5
Median 5Y
-49.3
Industry
6.3
vs History
47
vs Industry
28
Median 3Y
8.6
Median 5Y
9.8
Industry
5.7

Multiples Across Competitors

THTX Competitors Multiples
Theratechnologies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Theratechnologies Inc
NASDAQ:THTX
205.5m USD 1.8 -16.4 17.2 21.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 790 068.7 -160 599.2 -195 018.6 -192 793.3
US
Abbvie Inc
NYSE:ABBV
403.8B USD 6.8 172 16.6 23.6
US
Amgen Inc
NASDAQ:AMGN
176.1B USD 4.9 25.1 18.1 18.1
US
Gilead Sciences Inc
NASDAQ:GILD
152.4B USD 5.2 18.8 12.6 12.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.2B USD 9.8 31.3 23 24
US
Epizyme Inc
F:EPE
94.1B EUR 2 084.9 -532 -579.3 -563.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD 5.7 17.8 16.9 19.2
AU
CSL Ltd
ASX:CSL
83.3B AUD 3.6 18.5 12.5 15.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.4B USD 16.3 1 203 162.2 196.7
NL
argenx SE
XBRU:ARGX
43.8B EUR 14.3 33.6 57.9 59.5
P/E Multiple
Earnings Growth PEG
CA
Theratechnologies Inc
NASDAQ:THTX
Average P/E: 190
Negative Multiple: -16.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 599.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
172
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.8
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.3
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
10%
1.8
AU
CSL Ltd
ASX:CSL
18.5
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 203
N/A N/A
NL
argenx SE
XBRU:ARGX
33.6
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Theratechnologies Inc
NASDAQ:THTX
Average EV/EBITDA: 37.5
17.2
47%
0.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 018.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.6
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.1
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.6
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
11%
1.5
AU
CSL Ltd
ASX:CSL
12.5
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
162.2
N/A N/A
NL
argenx SE
XBRU:ARGX
57.9
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Theratechnologies Inc
NASDAQ:THTX
Average EV/EBIT: 43.4
21.2
37%
0.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 793.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.6
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.1
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.6
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
13%
1.5
AU
CSL Ltd
ASX:CSL
15.6
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
196.7
N/A N/A
NL
argenx SE
XBRU:ARGX
59.5
N/A N/A